Evidence map›Paper›PMID 32865261›Full record

ReviewThe EMBO journal2020

Roles of plant retinoblastoma protein: cell cycle and beyond.

Bénédicte Desvoyes, Crisanto Gutierrez

Open access · hybridAbstract readReview
In one paragraph

Review in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 102 citations in OpenAlex.

  1. Cyclin' Through the Root: Developmental Control of Cell Cycle Progression in theAnnual review of cell and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bénédicte DesvoyesCentro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.
Crisanto GutierrezCentro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.ORCID 0000-0001-8905-8222
Centro de Biología Molecular Severo Ochoa · ES

Funding

EC | H2020 | H2020 Priority Excellent Science | H2020 European Research Council (ERC) ERC-2018-AdG_833617Ministerio de Ciencia, Innovación y Universidades (Ministry of Science, Innovation and Universities) BIO2017-92329-EXPMinisterio de Ciencia, Innovación y Universidades (Ministry of Science, Innovation and Universities) RTI2018-094793-B-I00
6 · The paper itself

Abstract

The human retinoblastoma (RB1) protein is a tumor suppressor that negatively regulates cell cycle progression through its interaction with members of the E2F/DP family of transcription factors. However, RB-related (RBR) proteins are an early acquisition during eukaryote evolution present in plant lineages, including unicellular algae, ancient plants (ferns, lycophytes, liverworts, mosses), gymnosperms, and angiosperms. The main RBR protein domains and interactions with E2Fs are conserved in all eukaryotes and not only regulate the G1/S transition but also the G2/M transition, as part of DREAM complexes. RBR proteins are also important for asymmetric cell division, stem cell maintenance, and the DNA damage response (DDR). RBR proteins play crucial roles at every developmental phase transition, in association with chromatin factors, as well as during the reproductive phase during female and male gametes production and embryo development. Here, we review the processes where plant RBR proteins play a role and discuss possible avenues of research to obtain a full picture of the multifunctional roles of RBR for plant life.

Indexed as

Asymmetric Cell DivisionCell DivisionG2 PhaseHumansPlant ProteinsPlantsRetinoblastoma ProteinSeedsPlant ProteinsRetinoblastoma ProteinArabidopsisCDK/cyclincell differentiationchromatinendoreplication

Identifiers

PMID32865261
PMCPMC7527812
OpenAlexW3082936857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.